Vamsi Pharma Private Limited (VPPL) was established in 2015. It's a company founded by the board members of Vamsi Labs Limited (VLL) which was started in 1992.
The DPI segment is the fastest growing form of drug delivery for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
VPPL has an API manufacturing facility designed to comply to cGMP. The facility is created with an aim to cater global markets including Advanced market